MONTREAL — An investigational targeted immunotherapy for Guillain-Barré syndrome (GBS) more than doubled improvement in disability after 8 weeks compared with placebo and showed sustained benefit at ...

Annexon (ANNX) announced topline results from a real-world evidence study supporting ANX005 as a potential treatment for Guillain-Barre Syndrome. GBS is a rapid-onset and acute neuromuscular disease ...

Ali Sudderth, a 33-year-old woman said that she woke up with "tingly" toes and slowly her entire body became numb and she ...

Jess Branson, of Westport, had a busy career and an active social life. But in the spring of 2021, Branson's life "went from 60 to zero in a heartbeat" when she became unable to move. It all began ...

"Recovery is excellent with the proper treatment and the proper therapy," he explained, adding that risk factors include older age and already have an auto-immune disease. May is Guillain-Barre ...

Jess Branson, of Westport, had a busy career and an active social life. But in the spring of 2021, Branson's life "went from 60 to zero in a heartbeat" when she became unable to move. It all began ...

The number of people diagnosed with Guillain-Barre Syndrome (GBS), a rare neurological disorder, in Pune has increased to 158, with a total of 38 patients discharged after recovery so far. In ...